Check Point Software Technologies Ltd. (0Y9S)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 159.26 |
|---|---|
| 52-week range | 111.80 – 210.90 |
| Return, 1 month / 3 months | +20.7% / +18.7% |
| Return, 1 year / 3 years | −17.5% / +20.8% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 41.7% |
| Worst drawdown (1 year) | -44.8% |
| Average daily value traded | 0.20M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Check Point Software Technologies is a cybersecurity company based in Israel. It develops software and appliances that protect networks, endpoints, cloud environments and mobile devices from cyber threats. Its products include firewalls, virtual private network gateways, threat prevention and security management tools. Customers are mainly businesses, government bodies and other organisations that need to secure their computer systems and data. The company also provides security support and subscription services alongside its products.
Check Point Software Technologies Ltd. trades under the code 0Y9S on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Check Point Software Technologies Ltd. (0Y9S) trades on the London Stock Exchange in UK. It last closed at USD 159.26 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,327 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.5% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.3% | ||
| From 52-week high | -22.3% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 18.7% | ||
| 6-month return | 15.0% | ||
| 12-month return, skipping the last month | -31.6% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.8% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.20M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +14.0% |
|---|---|
| 1 month | +20.7% |
| 3 months | +18.7% |
| 6 months | +15.0% |
| 1 year | −17.5% |
| 3 years | +20.8% |
| 5 years | +34.3% |
Signals
| 50-day / 200-day average | 136.08 / 141.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.70 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.